X @Bloomberg
Bloomberg·2025-09-11 03:08
Buyout firm GTCR is nearing a deal to buy generic drugmaker Zentiva in a deal that could be valued at about $4.8 billion, according to people familiar with the matter. https://t.co/UaaAEtVDE7 ...
Buyout firm GTCR is nearing a deal to buy generic drugmaker Zentiva in a deal that could be valued at about $4.8 billion, according to people familiar with the matter. https://t.co/UaaAEtVDE7 ...